Clinical Efficacy of Temocillin Standard Dosing in Patients Treated with Outpatient Antimicrobial Therapy
In 2020, EUCAST introduced breakpoints for temocillin. Based on these guidelines, reporting of temocillin susceptibility of <i>Enterobacterales</i> in the context of complicated urinary tract infections (cUTI) implicates the use of a high dose of temocillin (2 g q8h) constantly. We aimed...
Main Authors: | Evelyne Van den Broucke, Lore Thijs, Stefanie Desmet, Lotte Vander Elst, Matthias Gijsen, Marnix Mylemans, Otto Van de Gaer, Willy E. Peetermans, Charlotte Quintens, Isabel Spriet |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/11/2289 |
Similar Items
-
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic
by: Tommaso Lupia, et al.
Published: (2022-04-01) -
Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion
by: Perrin Ngougni Pokem, et al.
Published: (2022-07-01) -
Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program
by: Lore Thijs, et al.
Published: (2022-05-01) -
New and simplified method for drug combination studies by checkerboard assay
by: Pierangelo Bellio, et al.
Published: (2021-01-01) -
Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study
by: Ortiz-Álvarez A, et al.
Published: (2018-12-01)